Vaxcyte, Inc. · NASDAQ:PCVX

Cowan Elvia sold 3,000 Vaxcyte, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 4, 2026

On Nov 2, 2026, Cowan Elvia (SVP, Finance & CAO) sold 3,000 Vaxcyte, Inc. shares at an average US$60.92 for US$183K under a trading plan, leaving 27,860 shares. Filed Nov 4, 2026 (Form 4).

Sold
3,000 shares
Price
US$60.92 average (US$60.77 to US$61.55)
Value
US$183K
Holding after
27,860 shares
Trading plan
Yes (Made under a plan set in advance)
Role
SVP, Finance & CAO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockOption exercise3,000US$25.9230,860Direct
Nov 2, 2026Common StockSale2,414US$60.7728,446Direct
Nov 2, 2026Common StockSale586US$61.5527,860Direct

Source

Download original · View original at SEC

Related